Premium
Bladder cancer redefined
Author(s) -
Murphy William M.
Publication year - 1999
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19991115)86:10<1890::aid-cncr2>3.0.co;2-j
Subject(s) - medicine , cytopathology , urothelial cancer , bladder cancer , cancer , pathology , cytology
The recent World Health Organization/International Society of Urological Pathology classification of urothelial neoplasms should redefine the clinical as well as the pathologic approach to “bladder cancer.” Separating benign tumors associated with a low risk for the subsequent development of cancer from true carcinomas should emphasize the importance of cytopathology for monitoring, decrease the percentage of truly superficial bladder carcinomas, and benefit patients who present with low grade, noninvasive, papillary urothelial neoplasms. See also pages 2098–101 and 2102–8.